Arcturus Therapeutics Holdings Inc (ARCT)

Finanzdaten der Arcturus Therapeutics Holdings Inc-Aktie (ARCT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	518.35%18.30	2.96	2.06	7.20	17.15
	3.59%27.48	28.50	30.99	38.50	33.66
Research and Development	2.95%17.00	17.52	21.53	24.48	23.27
Depreciation and Amortization	0.60	0.60	0.66	0.68	0.80
Operating Income/Loss	64.04%-9.19	-25.55	-28.93	-31.31	-16.51
Income/Loss From Continuing Operations Before Tax	68.83%-7.41	-23.79	-	-29.08	-13.45
Income Tax Expense/Benefit	-	-	-	-	-
	68.83%-7.41	-23.79	-26.96	-29.08	-13.45
Attributable To Parent	68.83%-7.41	-23.79	-26.96	-29.08	-13.45
Basic Average Shares	0.06%28.44	28.42	28.42	0.24	27.19
Diluted Average Shares	0.06%28.44	28.42	28.42	0.24	27.19
Basic Earnings Per Share	69.05%-0.26	-0.84	-0.95	-1.05	-0.49
Diluted Earnings Per Share	69.05%-0.26	-0.84	-0.95	-1.05	-0.49